Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278421
Status:
COMPLETED
Last Update Posted:
2021-03-11
First Post:
2006-01-16
Brief Title:
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkins Lymphoma
Sponsor:
German High-Grade Non-Hodgkins Lymphoma Study Group
Organization:
German High-Grade Non-Hodgkins Lymphoma Study Group
Organization Data
Organization:
German High-Grade Non-Hodgkins Lymphoma Study Group
Class:
OTHER
Study ID:
CDR0000459685
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German High-Grade Non-Hodgkins Lymphoma Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None